qwertyuiopasdfghjklzxcvbnmqwerty

uiopasdfghjklzxcvbnmqwertyuiopasd
fghjklzxcvbnmqwertyuiopasdfghjklzx
cvbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmqwertyuiopasdfghjklzxc
vbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
NIFTY OUTLOOK
hjklzxcvbnmqwertyuiopasdfghjklzxc
REPORT
vbnmqwertyuiopasdfghjklzxcvbnmq
th
12 July 2017
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmrtyuiopasdfghjklzxcvbn
mqwertyuiopasdfghjklzxcvbnmqwert
yuiopasdfghjklzxcvbnmqwertyuiopas
 12th July 2017

NIFTY

NIFTY FUT : R1:9826 R2:9860 R3:9900

PIVOT : 9798 S1:9768 S2:9750 S3:9730

NIFTY INTRADAY CHART

NIFTY OUTLOOK
Nifty is likely to open in a marginal positive note. Bears are dragged by the bulls and we are expecting they will
be dragged till 9990.Momentum indicators are indicating towards bullish trading sessions ahead. Positional
traders are advised to cover their longs and get ready to make new shorts around 9990 with a very small stop
loss of 10101 for the target of 9600.Intraday traders are advised to adopt buy on dips strategy for the day.

Strategy: buy nifty around 9760 with a stop loss of 9720 for the target of 9860.

Name Current Value Change % Chg Open High Low

FTSE 100 (Jul 11) 7,329.76 -40.27 -0.55 7,370.03 7,386.88 7,304.77
CAC 40 (Jul 11) 5,140.60 -25.04 -0.49 5,172.03 5,186.44 5,135.95
DAX (Jul 11) 12,437.02 -8.9 -0.07 12,479.67 12,539.18 12,417.85

Nikkei 225 (Jul 12) 20,120.03 -75.45 -0.37 20,137.22 20,153.04 20,105.71
Straits Times (Jul
12) 3,208.49 -10.31 -0.32 3,219.67 3,223.36 3,206.21

Hang Seng (Jul 12) 26,098.56 220.92 0.85 25,991.35 26,147.30 25,991.35

Taiwan Weighted
(Jul 12) 10,434.65 19.08 0.18 10,396.97 10,450.87 10,393.54

SGX Nifty (Jul 12) 9,805.00 11 0.11 9,793.00 9,814.00 9,771.50

WWW.EQUITYRESEARCHLAB.COM
 12th July 2017

CORPORATE NEWS
Vista Pharma
-US FDA issues warning letter to Vista Pharmas Telangana unit
-US FDA issues 2 observations for Telangana unit, inspected from September 19-23, 2016
-Warnings letter summarises significant violations of current good manufacturing practice regulations for
finished drugs
US FDA observations
-Company failed to clean, maintain equipment, utensils at appropriate intervals
-Company failed to establish procedures to assure drug strength, identity, quality

Adani Power says

-To transfer Mundra Power unit to subsidiary
-Board approved demerger of Mundra Power to a subsidiary with assets & liabilities

-SME IPOs listing - Transwind Infrastructures, Bansal Multiflex

-HMT to close 3 subsidiaries and dispose of their assets
-UCO Bank employees to go on strike on July 15
-Reliance Industries says Jio Prime members to enjoy all unlimited for 3 months with Rs 399 plan
-Godrej Consumer Products drops soap prices up to 8 percent, expects positive in second half of FY18
-NCLT asks United Bank to clarify on Era Infra
-ICICI Bank and Fairfax to sell 20 percent stake in ICICI Lombard IPO
-Maruti Suzuki takes pole position in utility vehicle market in Q1FY18: Mint
-Tata Global Beverage to divest stake in groups firm to parent: BS

WWW.EQUITYRESEARCHLAB.COM
 12th July 2017

ERL RESEARCH TEAM

Member Name Designation

Mr. Tuhinanshu Jain Research Head
Mr. Manish Bimal Sr. Research Analyst
Mr. Anand Sharma Research Analyst
Mr. Yash Sharma Research Analyst

DISCLAIMER

The information and views in this report, our website & all the service we provide are believed to be
reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have
the right to choose the product/s that suits them the most. Investment in Stocks has its own risks.
Sincere efforts have been made to present the right investment perspective. The information contained
herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch
for the accuracy or the completeness thereof. This material is for personal information and we are not
responsible for any loss incurred based upon it & takes no responsibility whatsoever for any financial
profit s or loss which may arise from the recommendations above. The stock price projections shown
are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice.

Equity Research Lab does not purport to be an invitation or an offer to buy or sell any financial
instrument. Analyst or any person related to Equity Research Lab might be holding positions in the
stocks recommended. It is understood that anyone who is browsing through the site has done so at his
free will and does not read any views expressed as a recommendation for which either the site or its
owners or anyone can be held responsible for. Any surfing and reading of the information is the
acceptance of this disclaimer.

Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our
calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly
or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of
the information is the acceptance of this disclaimer.

ALL RIGHTS RESERVED.

WWW.EQUITYRESEARCHLAB.COM